A phase I–II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma
- 1 September 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (9) , 1439-1443
- https://doi.org/10.1016/0277-5379(88)90334-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.Journal of Clinical Oncology, 1987
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- Alternatives to CYVADIC combination therapy of soft tissue sarcomasCancer Chemotherapy and Pharmacology, 1986
- Ifosfamide plus mesna with and without adriamycin in soft tissue sarcomaCancer Chemotherapy and Pharmacology, 1986
- Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma groupCancer, 1984
- High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcomaCancer Chemotherapy and Pharmacology, 1983
- CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN, AND DTIC (CYVADIC) COMBINATION CHEMOTHERAPY FOR THE TREATMENT OF ADVANCED SARCOMAS1980
- Chemotherapy of advanced soft-tissue sarcomas in adultsCancer Treatment Reviews, 1977
- Phase II evaluation of adriamycin in human neoplasiaCancer, 1973